Searchable abstracts of presentations at key conferences in endocrinology

ea0028p178 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2012

Ablation of Peptide YY cells in adult mice reveals a role in beta-cell maintenance

Sam Amir , King Aileen , Hostomska Klara , Persaud Shanta , Liu Bo , Ghatei Mohammad , Bloom Stephen , Bewick Gavin

In the pancreas, PYY is expressed in a subpopulation of non-beta cells in the islets of Langerhans. The role of PYY-expressing cells in the adult pancreas is unknown. We generated a mouse model in which administration of diphtheria toxin (DT) produced specific ablation of PYY-expressing cells in the colon, pancreas and brainstem. Interestingly, DT administration to adult mice resulted in severe hyperglycaemia associated with significant loss of pancreatic insulin and disrupted...

ea0021p237 | Neuroendocrinology and behaviour | SFEBES2009

Profiling the metabolic clearance and enzymatic degradation of the gut hormone Peptide YY as a tool to design long-acting PYY3–36 analogues in treating obesity

Addison Melisande , Thompson Emily , Minnion James , Murphy Kevin , Ghourab Samar , Hostomska Klara , Ghatei Mohammad , Bloom Stephen

Peptide YY (PYY) is a satiety hormone that communicates nutritional status to the central nervous system. PYY is released postprandially from endocrine L-cells in proportion to calories consumed. It is processed to generate the principle bioactive form PYY3–36, which acts on Y2 receptors in feeding centres within the brainstem and hypothalamus to reduce appetite. Chronic intravenous infusion of PYY3–36 induces weight loss in rodents, and obese humans display low plas...

ea0028p190 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2012

Investigating the sites and mechanisms by which peripheral prokineticin 2 administration reduces food intake and body weight in mice

Beale Kylie , Gardiner James , Bewick Gavin , Hostomska Klara , Patel Neekhil , Hussain Syed , Ebling Francis , Jethwa Preeti , Prosser Haydn , Ghatei Mohammad , Bloom Stephen , Dhillo Waljit

Prokineticin 2 (PK2) is a neuropeptide expressed in hypothalamic nuclei involved in the regulation of energy homeostasis, and has been shown to acutely reduce food intake in rodents. PK2 binds to and activates two G protein-coupled receptors, the PK receptor 1 (PKR1) and the PK receptor 2 (PKR2). We aimed to determine the sites and receptors which mediate the anorectic effects of peripherally administered PK2 within the CNS. We investigated neuronal activity in the hypothalamu...